Brief: Glycomimetics Inc Says CEO Harout Semerjian And CFO Brian Hahn To Step Down
31/01/2025 23:32
Jan 31 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS INC - CEO HAROUT SEMERJIAN AND CFO BRIAN
HAHN TO
STEP DOWN
Source text: ID:n0001558370-25-000576
Further company coverage: GLYC.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering